Background: Pre-exposure prophylaxis (PrEP) is highly effective for HIV-1 prevention. Some studies have suggested an antagonistic interaction between PrEP and hormonal contraception, with both biologic and behavioral mechanisms hypothesized. Evidence is needed to ensure PrEP and hormonal contraception can be effectively used together. We evaluated whether PrEP reduces hormonal contraceptive effectiveness for pregnancy prevention. Methodology: In a clinical trial of PrEP (the Partners PrEP Study), 1785 HIV-1 uninfected women and their HIV-1 infected male partners were randomized to tenofovir or co-formulated tenofovir-emtricitabine PrEP or placebo and followed for up to 3 years. Contraception was not required for study participation, was offered on-site, and was recorded monthly; incident pregnancy was determined by monthly urine pregnancy testing. We estimated the contraceptive effectiveness of hormonal contraceptive methods (oral contraceptive pills, injectable contraception, and contraceptive implants) compared to no contraception using the Andersen-Gill extension of Cox proportional hazards and compared contraceptive effectiveness for women assigned to PrEP versus placebo. Estimates were adjusted for age, number of children, partnership duration, sexually transmitted infections at enrollment, any unprotected sex, sexual frequency, and antiretroviral therapy use by HIV-1 infected partners. Results: Among women reporting no contraceptive use, pregnancy incidence was 14.6% per year among women assigned PrEP and 17.4% per year among women assigned placebo (Table). Women reporting oral contraceptive use had similar pregnancy incidence compared to women using no contraception and this effect was similar for women assigned PrEP and placebo (interaction p=0.22). Women reporting injectable contraception had substantial protection from pregnancy which did not differ by randomization arm (PrEP: HR 0.3, p<0.001; placebo: HR 0.2, p<0.001; interaction p=0.45). Contraceptive efficacy was highest among women using contraceptive implants (incidence <1%/year). Conclusions: PrEP had no adverse impact on contraceptive effectiveness for pregnancy prevention. As seen in prior studies in similar populations, oral contraceptive pills provided little reduction in pregnancy incidence, possibly due to poor adherence. A combination of injectable or implantable hormonal contraception plus PrEP provides effective prevention for pregnancy and HIV-1.